Ken Griffin Edwards Lifesciences Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 475,900 shares of EW stock, worth $33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
475,900
Previous 592,100
19.63%
Holding current value
$33 Million
Previous $56.6 Million
22.31%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding EW
# of Institutions
1,362Shares Held
468MCall Options Held
2.45MPut Options Held
2.56M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.71 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.53 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.8 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.41 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.17 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $42.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...